Analysis of the α-glucosidase inhibitory activity of chromenone derivatives based on their molecular features: A computational study

Medicinal Chemistry

Volumn 7, Issue 6, 2011, Pages 526-533

  Moorthy, N S Hari Narayana ^a   Ramos, Maria J ^a   Fernandes, Pedro A ^a  

^a UNIVERSITY OF PORTO   (Portugal)

Author keywords

Chromenone; LogS; QSAR; SMR VSA4; glucosidase inhibitors

Indexed keywords

ALPHA GLUCOSIDASE; ALPHA GLUCOSIDASE INHIBITOR; CHROMENE DERIVATIVE;

ARTICLE; HYDROGEN BOND; MATHEMATICAL COMPUTING; PHARMACOPHORE; PHYSICAL CHEMISTRY; POLARIZATION; PRIORITY JOURNAL; QUANTITATIVE STRUCTURE ACTIVITY RELATION; SOLUBILITY; SURFACE PROPERTY; VALIDATION PROCESS;

EID: 80755125976     PISSN: 15734064     EISSN: 18756638     Source Type: Journal    
DOI: 10.2174/157340611797928389     Document Type: Article

References (38)

1. Park, H.; Hwang, K.Y.; Kim, Y.H.; Oh, K.H.; Lee, J.Y.; Kim, K. Discovery and biological evaluation of novel α-glucosidase inhibitors with in vivo antidiabetic effect. Bioorg. Med. Chem. Lett., 2008, 18, 3711-3715. (Pubitemid 351794515)
2. Kimura, A.; Lee, J.-H.; Lee, I.-S.; Lee, H.-S.; Park, K.-H.; Chiba, S.; Kim, D. Two potent competitive inhibitors discriminating alpha-glucosidase family I from family II. Carbohydr. Res., 2004, 339, 1035-1040. (Pubitemid 38519916)
3. Phuwapraisirisan, P.; Puksasook, T.; Jong-aramruang, J.; Kokpol, U. Phenylethyl cinnamides: A new series of α-glucosidase inhibitors from the leaves of Aegle marmelos. Bioorg. Med. Chem. Lett., 2008, 18, 4956-4958.
4. Melo, E.B.; Gomes, A.S.; Carvalho, I. β-and α-glucosidase inhibitors: Chemical structure and biological activity. Tetrahedron, 2006, 62, 10277-10302. (Pubitemid 44397114)
5. Wang, S.; Yan, J.; Wang, X.; Yang, Z.; Lin, F.; Zhang, T. Synthesis and evaluation of the α-glucosidase inhibitory activity of 3-[4-(phenylsulfonamido)benzoyl]-2H-1-benzopyran-2-one derivatives. Eur. J. Med. Chem., 2010, 45, 1250-1255.
6. Fujisawa, T.; Ikegami, H.; Inoue, K.; Kawabata, Y.; Ogihara, T. Effect of two α-glucosidase inhibitors, voglibose and acarbose, on postprandial hyperglycemia correlates with subjective abdominal symptoms. Metab.-Clin. Exp., 2005, 54, 387-390. (Pubitemid 40250100)
7. Gunawan-Puteri, M.D.P.T.; Kawabata, J. Novel α-glucosidase inhibitors from Macaranga tanarius leaves. Food Chem., 2010, 123, 384-389.
8. Scott, L.J.; Spencer, C.M. Miglitol: A review of its therapeutic potential in type 2 diabetes mellitus. Drugs, 2000, 59, 521-549. (Pubitemid 30213863)
9. Robinson, K.M.; Begovic, M.E.; Rhinehart, B.L.; Heineke, E.W.; Ducep, J.-B.; Kastner, P.R.; Marshall, F.N.; Danzin, C. New potent β- glucohydrolase inhibitor MDL 73945 with long duration of action in rats. Diabetes, 1991, 40, 825-830.
10. Silva, C.H.T.P.; Taft, C.A. Computer aided molecular design of novel glucosidase inhibitors for AIDS treatment. J. Biomol. Struct. Dyn., 2004, 22, 59-63. (Pubitemid 39095283)
11. Jung-Hum, P.; Sungmin, K.; Hwangseo, P. Toward the virtual screening of α-glucosidase inhibitors with the homology-modelled protein structure. Bull. Korean Chem. Soc., 2008, 29, 921-927.
12. Kavitha, B.; Nagakumar, B.; Ki, H.P.; Keun, W.L. Binding mode analyses and pharmacophore model development for sulphonamide chalcone derivatives, a new class of α-glucosidase inhibitors. J. Mol. Graph. Model., 2008, 26, 1202-1212.
13. Moorthy, N.S.H.N.; Trivedi, P. QSAR modelling of some 2-methoxy acridones: Cytotoxic in multi drug resistant cells. Int. J. Cancer Res., 2006, 2, 267-276. (Pubitemid 46705976)
14. Moorthy, N.S.H.N.; Karthikeyan, C.; Trivedi, P. QSAR studies on cytotoxic acridine 5,7 diones: A comparative study using P-VSA descriptors and topological descriptors. Indian J. Chem. (B), 2007, 46B, 177-184.
15. Moorthy, N.S.H.N.; Ramos, M.J.; Fernandes, P.A. Prediction of the relationship between the structural features of andrographolide derivatives and α-glucosidase inhibitory activity: A quantitative structure activity relationship (QSAR) study. J. Enz. Inhibit. Med. Chem., 2011, 26(1), 78-87.
16. Moorthy, N.S.H.N.; Ramos, M.J.; Fernandes, P.A. QSAR analysis of isosteviol derivatives as α-glucosidase inhibitors with element count and other descriptors. Lett. Drug Des. Dis., 2011, 8, 14-25.
17. Moorthy, N.S.H.N.; Ramos, M.J.; Fernandes, P.A. Topological, hydrophobicity and other descriptors on α-glucosidase inhibition: A QSAR study on xanthone derivatives. J. Enz. Inhibit. Med. Chem., 2011 (Article in Press) (DOI: 10.3109/14756366.2010.549089).
18. Raju, B.C.; Tiwari, A.K.; Kumar, J.A.; Ali, A.Z.; Agawane, S.B.; Saidachary, G.; Madhusudana, K. α-glucosidase inhibitory antihyperglycemic activity of substituted chromenone derivatives. Bioorg. Med. Chem., 2010, 18, 358-365.
19. Prasanna, S.; Manivannan, E.; Chaturvedi, S.C. Quantitative structure activity relationship analysis of a series of 2,3-diaryl benzopyran analogues as novel selective cyclooxygenase-2 inhibitors. Bioorg. Med. Chem. Lett., 2004, 14, 4005-4011. (Pubitemid 38844414)
20. Chem BioOffice 2008, CambridgeSoft Corp, Cambridge, UK. 2008.
21. MOE is a molecular modelling package developed by chemical Computing Group Inc., Canada. 2002.
22. Statistica 8.0 statistical software, StatSoft, Inc. OK, USA. 2002.
23. Tropsha, A.; Gramatica, P.; Gombar, V.K. The importance of earnest, validation is the absolute essential application and interpretation of QSPR models. QSAR Comb. Sci., 2003, 22, 69-77. (Pubitemid 36717473)
24. 2. J. Mol. Graphs Model., 2002, 20, 269-276.
25. Gramatica, P. Principle of QSAR model validation: Internal and external. QSAR Comb. Sci., 2007, 26, 694-701. (Pubitemid 46932857)
26. Roy, P.P.; Roy, K. On some aspects of variable selected for partial least squares regression models. QSAR Comb. Sci. 2008, 27, 302-313.
27. Roy, P.P.; Paul, S.; Mitra, I.; Roy, K. On two novel parameters for validation of predictive QSAR models. Molecules, 2009, 14, 1660-1701.
28. Tuppurainen, K.; Viisas, M.; Laatikainen, R.; Perkyl, M. Evaluation of a novel eigenvalue (EEVA) molecular descriptor for QSAR/QSPR studies: Validation using a benchmark steroid data set. J. Chem. Inf. Comput. Sci., 2002, 42(3), 607-613. (Pubitemid 35359017)
29. Cook, R.D. Influential observations in linear-regression. J. Am. Stat. Assoc., 1979, 74, 169-174.
30. Rodriquez, G. Linear models for continuous data, Chapter 2, 1993-2000, 49-58. (http://data.princeton.edu/wws509/notes)
31. O'Brien, R.M. A caution regarding rules of thumb for variance inflation factors. Quality & Quantity, 2007, 41, 673-690.
32. Wood, F.S. Effect of centering on collinearity and interpretation of the constant. Am. Stat., 1984, 38, 88-90.
33. Durbin, J.; Watson, G.S. Testing for serial correlation in least squares regression.1. Biometrika, 1950, 37, 409-428.
34. Durbin, J.; Watson, G.S. Testing for serial correlation in least squares regression.2. Biometrika, 1951, 38, 159-178.
35. Lin, A. QuaSAR-descriptors. Chemical Computing Group Inc. Montreal, H3A 2R7 Canada, 2002.
36. Hou, T.J.; Xia, K.; Zhang, W.; Xu, X.J. ADME evaluation in drug discovery. 4. Prediction of aqueous solubility based on atom contribution approach. J. Chem. Inf. Comput. Sci. 2004, 44, 266-275.
37. Klopman, G.; Zhu, H. Estimation of the aqueous solubility of organic molecules by the group contribution approach. J. Chem. Inf. Comput. Sci. 2001, 41, 439-445. (Pubitemid 32408662)
38. Wildman, S.A.; Crippen, G.M. Prediction of physicochemical parameters by atomic contributions. J. Chem. Inf. Comput. Sci., 1999, 39, 868-873.